Clarivate's Journal Citation Reports (JCR) 2026 has delivered an appreciable result for Bentham Science Publishers: thirty-six of its peer-reviewed journals have recorded significant increases in Impact Factor, with gains concentrated in some of the most clinically urgent and scientifically dynamic disciplines of our time — Neuroscience & Neurology, Medicinal Chemistry, Pharmacology, and Gene Therapy.
These Impact Factors are more than bibliometric numbers. They are a signal from the global research community that Bentham Science journals are where consequential science is being published, read, and built upon.
Impact Factor Highlights (JCR 2026)
S. No.
Journal
IF
5-Yr IF
CiteScore
Indexing
1
Current Neuropharmacology
6.1
7.7
11.4
Scopus, SCI Exp., MEDLINE/PubMed
2
Current Gene Therapy
4.1
3.2
6.7
3
Mini-Reviews in Medicinal Chemistry
4.0
4.3
7.5
4
Current Topics in Medicinal Chemistry
3.6
3.5
6.6
5
Current Drug Targets
6.0
6
CNS & Neurological Disorders – Drug Targets
3.3
7.3
7
Current Medicinal Chemistry
3.7
6.5
8
Current Pharmaceutical Design
5.8
9
Current Drug Delivery
3.1
2.9
6.9
Leading the Gains: Three Journals That Demand Your Special Attention
Impact Factor: 6.1 | 5-Year IF: 7.7 | CiteScore: 11.4
In a global moment when neurological and psychiatric diseases have moved to the center of the public health agenda, Current Neuropharmacology has emerged as one of the most cited journals in its field. Its Scopus CiteScore of 11.4 also reflects how deeply its content is embedded in the citation networks of neuroscience and pharmacology worldwide.
The journal publishes comprehensive reviews, mini-reviews, position papers, high-impact research articles, clinical trials, and guest-edited issues spanning the molecular, cellular, and systems/behavioral dimensions of neuropharmacology and neuroscience. Indexed in Scopus, SCI Expanded, MEDLINE/PubMed, and other indexes, it is endorsed by Dr. Solomon H. Snyder of Johns Hopkins University — one of the most highly cited neuroscientists in history.
If your work touches pharmacological mechanisms of the nervous system — from receptor biology and synaptic pharmacology to clinical neurology and translational psychiatry — this is your journal.
Explore Current Neuropharmacology
Impact Factor: 4.1 | 5-Year IF: 3.2 | CiteScore: 6.7
Gene and cell therapy represent the most transformative frontier in modern medicine, and Current Gene Therapy is the peer-reviewed destination that covers this space in its entirety — from foundational science to clinical application. The journal encompasses gene transfer and expression analysis, vector development, cellular genetic engineering, animal disease models, human clinical trials, and the ethical and regulatory dimensions of gene therapy.
Indexed in Scopus, SCI Expanded, and MEDLINE/PubMed, and endorsed by Dr. Donald Kohn associated with the University of California, Los Angeles and USC School of Medicine — a pioneer in gene therapy for primary immune deficiencies — it carries the credibility of the field's own leadership. Whether your work involves CRISPR-based gene editing, AAV vector design, CAR-T cell engineering, or mRNA therapeutics, Current Gene Therapy offers the rigour, the audience, and the visibility your research deserves.
Impact Factor: 4 | 5-Year IF: 4.3 | CiteScore: 7.5
Mini-Reviews in Medicinal Chemistry is a peer-reviewed journal, endorsed by Nobel Laureate Prof. Jean-Marie Lehn as "an important review journal of great value to pharmaceutical scientists." Its scope spans quantitative structure-function relationships, synthetic and bioorganic chemistry, drug ADMET, pharmacogenomics, DILI, high-throughput screening, combinatorial chemistry, nanosystems and nanocarriers, and rational drug design.
What distinguishes the journal is its deliberate short-review format — precision-focused and designed for working scientists who need the field's most significant advances without delay. Mini-Reviews in Medicinal Chemistry ensures medicinal and pharmaceutical chemists stay consistently ahead of a rapidly evolving discipline.
Explore Mini-Reviews in Medicinal Chemistry
A Portfolio Built for the Full Width of Pharmacology & Biomedical Research
Beyond these three prominent journals, Bentham Science's broader portfolio of high-impact titles spans the complete landscape of pharmaceutical and biomedical research:
Publish Where Your Science Will Be Found
Bentham Science journals are indexed in Web of Science, Scopus, MEDLINE/PubMed, and other salient indexes — ensuring that your published work reaches the widest possible community of researchers and clinicians. Open Access articles are available on ScienceDirect, further maximizing discoverability and downstream citation impact.
To explore the full portfolio of Bentham Science journals, submit a manuscript, or browse by subject area, visit:
About Bentham Science Publishers:
Bentham Science is a leading science, technology, and medical publisher providing peer-reviewed journals and books to researchers and professionals worldwide. With more than 170 journals – hybrid and open access - covering pharmaceutical sciences, biomedical sciences, engineering, and beyond, Bentham Science is committed to the open and rigorous dissemination of scientific knowledge.